Clinical Trial Update: Paclitaxel in Treating Patients With Early-Stage Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials evaluating paclitaxel for early-stage bladder cancer have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Mary Babb Randolph Cancer Center at West Virginia University Hospitals | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED